Company Monitoring Page for Genentech

latest headlines for company on cafepharma

Genentech Distribution Shift for Cancer Meds Delays Patient Care: Survey
WSJ Pharmalot
Mon, 03/2/15 - 12:29 pm
Tags:
Genentech, Avastin, Rituxan, Herceptin, distribution
Regeneron Beats Genentech In Rare Face Off Over Diabetes-Related Vision Loss
Forbes
Thu, 02/19/15 - 10:38 am
Tags:
Regeneron, Genentech, diabetes, Eylea, Lucentis, DME, diabetic macular edema
FDA Grants Breakthrough Therapy Designation To Genetech’s Cancer Immunotherapy
Bidness Etc.
Tue, 02/3/15 - 09:07 am
Tags:
FDA, breakthrough therapies, Genentech, anti-PD-L1, MPDL3280A, non-small cell lung cancer
Exclusive: Constellation chops staff, plots go-it-alone strategy as Genentech option deadline looms
Fierce Biotech
Mon, 01/19/15 - 10:31 am
Tags:
Constellation Pharmaceuticals, Genentech
Surprise! With $60 Million Genentech Deal, 23andMe Has A Business Plan
Forbes
Tue, 01/6/15 - 11:29 am
Tags:
Genentech, 23andMe, diagnostics, Google Ventures
Exelixis' Partners File New Drug Application For Cobemetinib - Welcome News But Little Impact
Seeking Alpha
Tue, 12/16/14 - 08:08 am
Tags:
Exelixis, cobemetinib, Roche, Genentech
Genentech's top-billing Lucentis users are also top-paid speakers: NYT
Fierce Pharma
Tue, 12/9/14 - 07:55 am
Tags:
Genentech, Lucentis, physician payments
New Drugs Treat Advanced Stages of a Common Skin Cancer
WSJ Pharmalot
Tue, 11/25/14 - 10:58 am
Tags:
basal cell carcinoma, Erivedge, Genentech
Roche's Genentech defends supply shift for top cancer drugs
Yahoo/Reuters
Tue, 11/25/14 - 09:37 am
Tags:
Roche, Genentech, cancer, Avastin, Herceptin, Rituxan, distribution
Major Medical Centers ask Congress to Probe Genentech Distribution Shift
WSJ Pharmalot
Tue, 11/11/14 - 03:41 pm
Tags:
Genentech, distribution, Ascension
FDA accepts sBLA for Lucentis label expansion
Seeking Alpha
Wed, 10/8/14 - 01:06 pm
Tags:
FDA, Lucentis, Roche, Genentech, diabetic retinopathy
Genentech Sales Reps Face Hospital Bans Over a Wholesale Change
WSJ Pharmalot
Fri, 10/3/14 - 07:32 pm
Tags:
Genentech, drug reps, hospitals, distribution
Genentech shift could prove costly for hospitals
Medical Marketing and Media
Thu, 10/2/14 - 08:06 am
Tags:
Genentech
FDA says asthma drug Xolair raises risk of heart, brain problems
Reuters
Mon, 09/29/14 - 02:00 pm
Tags:
FDA, Xolair, asthma, Roche, Genentech
Roche's Genentech triggers its PhIII program for blockbuster AMD contender
Fierce Biotech
Mon, 09/15/14 - 10:51 am
Tags:
Roche, Genentech, AMD, Chroma, Spectri
FDA approves Avastin for aggressive and late-stage cervical cancer
Pharmaforum
Fri, 08/15/14 - 05:37 am
Tags:
FDA, cervical cancer, Avastin, Genentech, Roche
Genentech Submits sBLA for Diabetic Retinopathy Drug
Drug Discovery and Development
Fri, 08/8/14 - 05:08 pm
Tags:
Genentech, Roche, diabetic retinopathy, Lucentis
Genentech granted FDA orphan status for gastric cancer treatment
Yahoo/Fly on the Wall
Fri, 05/2/14 - 09:53 am
Tags:
Genentech, FDA, gastric cancer, cancer of the gastro-esophageal junction, orphan drugs, Ipatasertib
Genentech wins FDA approval for Xolair to treat hives
San Francisco Chronicle, CA
Sat, 03/22/14 - 12:19 pm
Tags:
Genentech, Xolair, hives
PDL Biopharma: Agreement With Genentech And Roche Is A Net Negative
Seeking Alpha
Tue, 02/4/14 - 09:58 am
Tags:
PDL Biopharma, Roche, Genentech, Avastin, Herceptin, Lucentis Xolair, Kadcyla, Perjeta, Lucentis

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.